RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer.

J Immunother Cancer · 2018 · PMC6245855 · PMID 30454021

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Even if not significant, a slight trend was observed for a better OS for patients treated with anti-EGFR (Additional file 2 : Figure S4D) while their HLA-score remained analogous compared to other NA regimen (Additional file 2 : Figure S4E).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.